Equities Analysts Issue Forecasts for Zoetis FY2024 Earnings

Zoetis Inc. (NYSE:ZTS - Free Report) - Research analysts at Zacks Research boosted their FY2024 earnings per share (EPS) estimates for shares of Zoetis in a report released on Monday, November 25th. Zacks Research analyst E. Bagri now forecasts that the company will earn $5.89 per share for the year, up from their previous estimate of $5.81. The consensus estimate for Zoetis' current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Zoetis' Q4 2024 earnings at $1.37 EPS, Q1 2025 earnings at $1.45 EPS, Q4 2025 earnings at $1.60 EPS, Q1 2026 earnings at $1.62 EPS and Q3 2026 earnings at $1.77 EPS.

Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts' consensus estimates of $1.46 by $0.12. The company had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. Zoetis's revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.36 EPS.

ZTS has been the topic of a number of other research reports. Argus raised shares of Zoetis to a "strong-buy" rating in a report on Friday, August 9th. BTIG Research raised their target price on Zoetis from $220.00 to $225.00 and gave the stock a "buy" rating in a research note on Monday, August 12th. Stifel Nicolaus boosted their price target on Zoetis from $200.00 to $210.00 and gave the company a "buy" rating in a report on Wednesday, September 18th. JPMorgan Chase & Co. increased their price objective on Zoetis from $225.00 to $230.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Finally, Piper Sandler boosted their target price on Zoetis from $195.00 to $210.00 and gave the company an "overweight" rating in a research note on Wednesday, August 14th. Ten analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $221.44.

Zoetis Trading Up 0.6 %

Shares of NYSE:ZTS traded up $1.04 during trading on Wednesday, reaching $176.74. 2,219,379 shares of the company traded hands, compared to its average volume of 2,550,097. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. Zoetis has a 52-week low of $144.80 and a 52-week high of $201.92. The business's fifty day moving average is $184.51 and its 200-day moving average is $180.81. The firm has a market capitalization of $79.74 billion, a price-to-earnings ratio of 33.22, a P/E/G ratio of 2.74 and a beta of 0.90.

Institutional Trading of Zoetis

Hedge funds have recently made changes to their positions in the stock. Darwin Wealth Management LLC purchased a new stake in Zoetis during the 3rd quarter valued at about $31,000. First Personal Financial Services purchased a new stake in shares of Zoetis during the third quarter valued at approximately $33,000. Capital Performance Advisors LLP bought a new stake in shares of Zoetis during the third quarter valued at approximately $33,000. Dunhill Financial LLC raised its holdings in Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company's stock worth $33,000 after acquiring an additional 75 shares during the last quarter. Finally, Quarry LP raised its holdings in Zoetis by 273.2% in the 2nd quarter. Quarry LP now owns 209 shares of the company's stock worth $36,000 after acquiring an additional 153 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Zoetis Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be issued a $0.432 dividend. This represents a $1.73 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date is Thursday, October 31st. Zoetis's dividend payout ratio (DPR) is presently 32.33%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.